NDSN

Business profile & competitive position

Nordson Corporation (NDSN) is classified in the Industrials sector, specifically the Industrial – Machinery industry. In plain terms, it engineers and manufactures precision technology systems that dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids. It also provides testing, inspection, surface-treatment, curing, and medical-product manufacturing capabilities, producing items such as catheters, cannulas, medical balloons, and tubing. The company organizes its operations into three segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions.

A useful way to think about Nordson’s competitive position is to look at its profitability metrics rather than rely on vague brand descriptions. The company reports a net margin of 18.6% and a return on equity (ROE) of 17.6%. In a capital-goods machinery business, margins in the high teens and an ROE near 18% usually point to pricing power derived from application-specific engineering, long-standing customer relationships, and recurring consumables and aftermarket revenue that accompany the installed base. No single customer accounts for 10% or more of sales, according to the company’s disclosures, which means the margin profile is not simply the result of reliance on one outsized contract. That said, high margins can also attract competition and capital, so the durability of the moat depends on continued product differentiation and execution.

Financial posture

Nordson carries an $18.1 billion market capitalization and trades at a trailing price-to-earnings ratio of 32.7. That multiple is a meaningful premium to many traditional industrial machinery names, implying the market is pricing in above-average growth and margin resilience. Net margin of 18.6% and ROE of 17.6% support that premium to some degree, though a P/E above 30 also leaves less room for disappointment.

The stock’s beta is 0.99, essentially 1.0, which means its day-to-day price sensitivity to the broader equity market is roughly in line with the S&P 500. As of the snapshot date, the share price stood at $324.6448, with a 50-day exponential moving average of $319.67 and RSI of 49.8—roughly neutral momentum by that common measure. Debt and leverage figures were not included in the provided real-data snapshot, so this assessment focuses on the valuation and profitability data that are available.

Strategic priorities & outlook

Nordson’s most recent 10-K lays out a strategy built around the “Ascend” program launched in 2021. The stated aim is to deliver top-tier revenue growth with leading margins and returns through three pillars: the NBS Next growth framework, an Owner Mindset division-led structure, and the Winning Teams talent strategy.

Operationally, NBS Next is described as a data-based segmentation process used to identify the highest-potential growth opportunities and direct investment accordingly. Organic growth is expected to come from new product introductions, customer service and support, expansion in emerging geographies, and applying existing technologies to new applications. On the inorganic side, the company plans acquisitions that bring differentiated precision-technology products, attractive high-growth end markets, and customer-centric business models.

The filing also notes that Nordson operates directly in more than 35 countries and generated approximately 67% of 2025 revenues outside the United States. As of October 31, 2025, the company had roughly 8,000 employees worldwide, with principal manufacturing facilities in the United States, China, Bulgaria, Germany, Ireland, Israel, Italy, Mexico, the Netherlands, and the United Kingdom. Management observes that global supply chains have stabilized, lead times have improved, and inflation risk has lessened, while cautioning that volatility in Asia-origin shipments and moderate rate increases in parcel and domestic trucking remain risks to monitor.

Macro & geopolitical exposure

As an industrial machinery company with two-thirds of revenue generated outside the U.S., Nordson is exposed to several macro forces by virtue of its industry and footprint. Currency translation is an obvious channel: a stronger U.S. dollar can reduce the dollar value of overseas sales and earnings, while a weaker dollar does the opposite. The global manufacturing cycle also matters; when industrial capital spending slows, demand for dispensing, coating, inspection, and curing equipment typically softens as well.

Trade policy and tariffs are evergreen risks for machinery businesses with multi-country manufacturing and supply chains. In addition, Nordson’s medical products segment brings exposure to healthcare regulation and FDA-style quality standards in multiple jurisdictions. Commodity and logistics costs play a role too—resin, metal, and shipping inputs influence margins, and the 10-K specifically flags ongoing volatility in Asia-origin shipments and trucking/parcel rate pressure as operational watch items.

Recent developments

Recent media coverage has centered on Nordson’s income and value characteristics rather than on operational updates:

• October 9, 2026: 5 Dividend Stocks That Turn Small Annual Raises Into Serious Long-Term Income (247wallst.com)
• October 8, 2026: Here's Why You Should Consider Investing in Nordson Stock Now (zacks.com)
• October 2, 2026: MWA or NDSN: Which Is the Better Value Stock Right Now? (zacks.com)
• September 26, 2026: Best Dividend Kings: September 2026 (seekingalpha.com)

These headlines highlight investor interest in dividend growth and relative valuation but do not disclose new fundamental data. They are best interpreted as market commentary rather than catalysts for the underlying business.

Earnings behavior & post-earnings drift

Over the last eight reported quarters, Nordson has beaten consensus earnings estimates six times, for a hit rate of 86%, with an average earnings surprise of 2.7%. The average five-day price move in the trading days after earnings across those quarters is 2.55%, classified as an upward post-earnings drift.

The most recent results illustrate the range of outcomes behind those averages:

• August 19, 2026: Actual EPS of $3.25 versus an estimate of $3.09, a 5.2% beat. The stock rose 8% the next day and 7.96% over the following five sessions.
• May 20, 2026: Actual EPS of $2.86 versus an estimate of $2.82, a 1.4% beat. The stock moved up 3.83% the next day and 4.32% over the next five sessions.
• February 18, 2026: Actual EPS of $2.37, exactly matching the $2.37 estimate (0% surprise). The stock fell 1.79% the next day and 2.83% over the following five sessions—showing that even an inline print can be sold if expectations had run ahead of the number.
• December 10, 2025: Actual EPS of $3.03 versus an estimate of $2.93, a 3.4% beat. The next-day move was a modest minus 0.8%, though the five-day drift turned positive at 0.74%.

Nordson is scheduled to report next on December 9, 2026, after the market close, with a consensus EPS estimate of $3.46. The historical record suggests the company usually clears the published estimate, but the magnitude and direction of the price reaction depend on how the result compares to the unofficial consensus, guidance tone, and broader market conditions at the time. For a deeper dive into how sell-side models and institutional ratings are positioned ahead of that report, readers should review the full institutional verdict.